Literature DB >> 1588426

Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen.

G L Rockswold1, S E Ford, D C Anderson, T A Bergman, R E Sherman.   

Abstract

The authors enrolled 168 patients with closed-head trauma into a prospective trial to evaluate the effect of hyperbaric oxygen in the treatment of brain injury. Patients were included if they had a total Glasgow Coma Scale (GCS) score of 9 or less for at least 6 hours. After the GCS score was established and consent obtained, the patient was randomly assigned, stratified by GCS score and age, to either a treatment or a control group. Hyperbaric oxygen was administered to the treatment group in a monoplace chamber every 8 hours for 1 hour at 1.5 atm absolute; this treatment course continued for 2 weeks or until the patient was either brain dead or awake. An average of 21 treatments per patient was given. Outcome was assessed by blinded independent examiners. The entire group of 168 patients was followed for 12 months, with two patients lost to follow-up study. The mortality rate was 17% for the 84 hyperbaric oxygen-treated patients and 32% for the 82 control patients (chi-squared test, 1 df, p = 0.037). Among the 80 patients with an initial GCS score of 4, 5, or 6, the mortality rate was 17% for the hyperbaric oxygen-treated group and 42% for the controls (chi-squared test, 1 df, p = 0.04). Analysis of the 87 patients with peak intracranial pressures (ICP) greater than 20 mm Hg revealed a 21% mortality rate for the hyperbaric oxygen-treated patients, as opposed to 48% for the control group (chi-squared test, 1 df, p = 0.02). Myringotomy to reduce pain during hyperbaric oxygen treatment helped to reduce ICP. Analysis of the outcome of survivors reveals that hyperbaric oxygen treatment did not increase the number of patients in the favorable outcome categories (good recovery and moderate disability). The possibility that a different hyperbaric oxygen treatment paradigm or the addition of other agents, such as a 21-aminosteroid, may improve quality of survival is being explored.

Entities:  

Mesh:

Year:  1992        PMID: 1588426     DOI: 10.3171/jns.1992.76.6.0929

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

Review 1.  Hyperoxia: good or bad for the injured brain?

Authors:  Michael N Diringer
Journal:  Curr Opin Crit Care       Date:  2008-04       Impact factor: 3.687

Review 2.  Disorders of Consciousness in China.

Authors:  Jizong Zhao
Journal:  Neurosci Bull       Date:  2018-07-23       Impact factor: 5.203

3.  Hyperbaric Oxygen Therapy in the Treatment of Acute Severe Traumatic Brain Injury: A Systematic Review.

Authors:  Samuel Daly; Maxwell Thorpe; Sarah Rockswold; Molly Hubbard; Thomas Bergman; Uzma Samadani; Gaylan Rockswold
Journal:  J Neurotrauma       Date:  2018-01-22       Impact factor: 5.269

4.  Hyperbaric oxygen. Restores normal metabolic activity.

Authors:  P James
Journal:  BMJ       Date:  1993-10-09

Review 5.  Clinical trials in traumatic brain injury: past experience and current developments.

Authors:  Andrew I R Maas; Bob Roozenbeek; Geoffrey T Manley
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 6.  Disorders of consciousness after acquired brain injury: the state of the science.

Authors:  Joseph T Giacino; Joseph J Fins; Steven Laureys; Nicholas D Schiff
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

7.  Hyperbaric oxygen therapy for the treatment of traumatic brain injury: a meta-analysis.

Authors:  Fei Wang; Yong Wang; Tao Sun; Hua-Lin Yu
Journal:  Neurol Sci       Date:  2016-01-08       Impact factor: 3.307

8.  A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population.

Authors:  Nathan K Evanson; Andrea L Paulson; Brad G Kurowski
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-02-17

9.  Post-traumatic cytotoxic edema is directly related to mitochondrial function.

Authors:  Eugene Vlodavsky; Eilam Palzur; Mona Shehadeh; Jean F Soustiel
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-15       Impact factor: 6.200

10.  Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Authors:  Daniel A Rossignol; Lanier W Rossignol; Scott Smith; Cindy Schneider; Sally Logerquist; Anju Usman; Jim Neubrander; Eric M Madren; Gregg Hintz; Barry Grushkin; Elizabeth A Mumper
Journal:  BMC Pediatr       Date:  2009-03-13       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.